STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

NYMX NYMOX PHARMACEUTICALS CORPORATION StockScouter® Report

3

StockScouter® Score

NYMOX PHARMACEUTICALS CORPORATION, a micro cap company in the healthcare sector, is expected to underperform the market over the next six months with higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive

 

Concerns

  • Short-term relative price momentum exhibits meaningful weakness. Negative
  • Shares are being sold by financial institutions. Slightly negative for a small company like NYMX

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 100% done.
Progress: 20% done.
Low
High

Core Model Grades

C
A
N/A
A

Previous Ratings

5
4